Co-Authors
This is a "connection" page, showing publications co-authored by RUTH L KATZ and COLIN P DINNEY.
Connection Strength
0.286
-
Use of fluorescence in situ hybridization to predict response to bacillus Calmette-Gu?rin therapy for bladder cancer: results of a prospective trial. J Urol. 2012 Mar; 187(3):862-7.
Score: 0.103
-
Relationship among cystectomy, microvessel density and prognosis in stage T1 transitional cell carcinoma of the bladder. J Urol. 1998 Oct; 160(4):1285-90.
Score: 0.041
-
DNA image analysis of urinary cytology: prediction of recurrent transitional cell carcinoma. Mod Pathol. 1996 May; 9(5):571-8.
Score: 0.035
-
Novel fluorescence in?situ hybridization-based definition of bacille Calmette-Gu?rin (BCG) failure for use in enhancing recruitment into clinical trials of intravesical therapies. BJU Int. 2016 May; 117(5):754-60.
Score: 0.033
-
The role of FISH and cytology in upper urinary tract surveillance after radical cystectomy for bladder cancer. Urol Oncol. 2012 Nov-Dec; 30(6):821-4.
Score: 0.024
-
Quantitation of Aurora kinase A gene copy number in urine sediments and bladder cancer detection. J Natl Cancer Inst. 2008 Oct 01; 100(19):1401-11.
Score: 0.020
-
Phase III prevention trial of fenretinide in patients with resected non-muscle-invasive bladder cancer. Clin Cancer Res. 2008 Jan 01; 14(1):224-9.
Score: 0.019
-
Urinary nuclear matrix protein 22 (NMP22): a diagnostic adjunct to urine cytologic examination for the detection of recurrent transitional-cell carcinoma of the bladder. Diagn Cytopathol. 1999 May; 20(5):285-90.
Score: 0.011